Clinical Trial Update: Prevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monotherapy Versus ZDV + 3TC + ABC [Phase 4]

View source ↗

Summary

Phase 4 trial comparing lopinavir/ritonavir monotherapy to zidovudine/lamivudine/abacavir triple therapy for preventing lipoatrophy in HIV-infected patients has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Epivir (Lamivudine)
• Kaletra (lopinavir)
• RETROVIR (Zidovudine)
• Ziagen (Abacavir)

Snippet

Sponsor: Fundacion SEIMC-GESIDA | Conditions: HIV Infection, HIV Infections | Phase 4 | Status: COMPLETED